Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Athira Pharma Has Completed Enrollment In The Phase 2/3 LIFT-AD Trial Of Fosgonimeton As A Potential Treatment For Mild-to-moderate Alzheimer's Disease; Topline data Is On Track For 2H Of 2024

Author: Benzinga Newsdesk | January 03, 2024 08:08am

Posted In: ATHA